Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Neurovirol. 2020 May 8;26(3):422–428. doi: 10.1007/s13365-020-00830-7

Fig. 1.

Fig. 1

Levels of amyloid and cellular amyloidogenic peptides from plasma of zoster and control subjects. (a) Plasma amyloid levels were significantly higher in zoster compared to non-zoster, control subjects (**p < 0.01). (b) No statistically significant differences in concentrations of Aβ40, Aβ42 or amylin were detected between zoster and control subjects (p > 0.05). (In; natural log).